Hypertriglyceridemia and pancreatitis in a patient with apolipoprotein E7 (p.[E244K; E245K])/E4

Clinica Chimica Acta

Volumn 436, Issue , 2014, Pages 188-192

  Arai, Makoto ^a   Nishimura, Akihiro ^a   Mori, Yasumichi ^a   Ebara, Tetsu ^b   Okubo, Minoru ^a,b  

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Apolipoprotein A V; Apolipoprotein E7; Hypertriglyceridemia; Pancreatitis; Variant

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E7; BEZAFIBRATE; GLUCOSE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID ETHYL ESTER; LIPOPROTEIN LIPASE; LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; APOLIPOPROTEINS E; PROTEIN ISOFORMS;

ADULT; AGAR GEL ELECTROPHORESIS; AMINO ACID SUBSTITUTION; ARTICLE; BODY MASS; CASE REPORT; CODON; DIABETES MELLITUS; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FATTY LIVER; GENE SEQUENCE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HAPLOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; JAPANESE (PEOPLE); MALE; NUCLEOTIDE SEQUENCE; PANCREATITIS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ACUTE DISEASE; BASE SEQUENCE; COMPLICATION; GENETICS; HUMANS; MIDDLE AGED;

ACUTE DISEASE; ADULT; APOLIPOPROTEINS E; BASE SEQUENCE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; PANCREATITIS; PHENOTYPE; PROTEIN ISOFORMS; SEQUENCE ANALYSIS;

EID: 84902589016     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.06.001     Document Type: Article

References (24)

1. Scherer J., Singh V.P., Pitchumoni C.S., Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol 2014, 48:195-203.
2. Murphy M.J., Sheng X., MacDonald T.M., Wei L. Hypertriglyceridemia and acute pancreatitis. JAMA Intern Med 2013, 173:162-164.
3. Hegele R.A., Ginsberg H.N., Chapman M.J., Nordestgaard B.G., Kuivenhoven J.A., Averna M., et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol 2014, (in press). DOI: 10.1016/S2213-8587(13)70191-8.
4. Bennet A.M., Di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007, 298:1300-1311.
5. Khan T.A., Shah T., Prieto D., Zhang W., Price J., Fowkes G.R., et al. Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals. Int J Epidemiol 2013, 42:475-492.
6. Okubo M., Aoyama Y., Harada K., Fukawa M., Tsukada T., Mokuno H., et al. A novel apolipoprotein E2 variant, E2 Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis. Atherosclerosis 1998, 140:187-190.
7. Yamamura T., Yamamoto A., Sumiyoshi T., Hiramori K., Nishioeda Y., Nambu S. New mutants of apolipoprotein E associated with atherosclerotic diseases but not to type III hyperlipoproteinemia. J Clin Invest 1984, 74:1229-1237.
8. Okubo M., Ishihara M., Iwasaki T., Ebara T., Aoyama Y., Murase T., et al. A novel APOA5 splicing mutation IVS2+1g>a in a Japanese chylomicronemia patient. Atherosclerosis 2009, 207:24-25.
9. Ebara T., Endo Y., Yoshiike S., Tsuji M., Taguchi S., Murase T., et al. A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis. Clin Chim Acta 2007, 386:100-104.
10. Okubo M., Horinishi A., Saito M., Ebara T., Endo Y., Kaku K., et al. A novel complex deletion-insertion mutation mediated by Alu repetitive elements leads to lipoprotein lipase deficiency. Mol Genet Metab 2007, 92:229-233.
11. Matsunaga A., Arishima H., Niimura H., Zhang B., Uehara Y., Ohwaki K., et al. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population. Circ J 2007, 71:746-752.
12. Wang J., Hegele R.A. Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650). Lipids Health Dis 2007, 6:23.
13. den Dunnen J.T., Antonarakis S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 2000, 15:7-12.
14. Maeda H., Nakamura H., Kobori S., Okada M., Mori H., Niki H., et al. Identification of human apolipoprotein E variant gene: apolipoprotein E7 (Glu244,245→Lys244,245). J Biochem 1989, 105:51-54.
15. Tajima S., Yamamura T., Menju M., Yamamoto A. Analysis of apolipoprotein E7 (apolipoprotein E-Suita) gene from a patient with hyperlipoproteinemia. J Biochem 1989, 105:249-253.
16. Yanagi K., Yamashita S., Hiraoka H., Ishigami M., Kihara S., Hirano K., et al. Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo E Suita). Atherosclerosis 1997, 131:49-58.
17. Ueyama Y., Nozaki S., Yanagi K., Hiraoka H., Nakagawa T., Sakai N., et al. Familial hypercholesterolaemia-like syndrome with apolipoprotein E-7 associated with marked Achilles tendon xanthomas and coronary artery disease: a report of two cases. J Intern Med 1994, 235:169-174.
18. Yamanouchi Y., Arinami T., Tsuchiya S., Miyazaki R., Takaki H., Takano T., et al. Apolipoprotein E5 and E7 in apparently healthy Japanese males: frequencies and relation to plasma lipid levels. Jpn J Hum Genet 1994, 39:315-324.
19. Matsunaga A., Sasaki J., Moriyama K., Arakawa F., Takada Y., Nishi K., et al. Population frequency of apolipoprotein E5 (Glu3→Lys) and E7 (Glu244→Lys, Glu245→Lys) variants in western Japan. Clin Genet 1995, 48:93-99.
20. Lopez-Miranda J., Williams C., Lairon D. Dietary, physiological, genetic and pathological influences on postprandial lipid metabolism. Br J Nutr 2007, 98:458-473.
21. Carvalho-Wells A.L., Jackson K.G., Gill R., Olano-Martin E., Lovegrove J.A., Williams C.M., et al. Interactions between age and apoE genotype on fasting and postprandial triglycerides levels. Atherosclerosis 2010, 212:481-487.
22. Johansen C.T., Hegele R.A. The complex genetic basis of plasma triglycerides. Curr Atheroscler Rep 2012, 14:227-234.
23. Kao J.T., Wen H.C., Chien K.L., Hsu H.C., Lin S.W. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 2003, 12:2533-2539.
24. Pullinger C.R., Aouizerat B.E., Movsesyan I., Durlach V., Sijbrands E.J., Nakajima K., et al. An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients. J Lipid Res 2008, 49:1846-1854.